Amgen Inc (NASDAQ:AMGN)
| 247.70 Delayed Data As of Sep 18 |  -0.38 / -0.15%Today’s Change | 177.05 Today|||52-Week Range 264.97 | +2.75% Year-to-Date |
Latest AMGN News | Press Releases
Today’s Trading
| Previous close | 248.08 |
| Today’s open | 248.50 |
| Day’s range | 242.41 - 249.88 |
| Volume | 164,204 |
| Average volume (3 months) | 2,730,673 |
| Market cap | $145.1B |
Data as of 4:19pm ET, 09/18/2020
Growth & Valuation
| Earnings growth (last year) | +2.07% |
| Earnings growth (this year) | +6.39% |
| Earnings growth (next 5 years) | +7.07% |
| Revenue growth (last year) | -2.13% |
| P/E ratio | 20.2 |
| Price/Sales | 6.31 |
| Price/Book | 15.15 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GILDGilead Sciences | +0.01 | +0.02% |
| BIIBBiogen | -0.89 | -0.32% |
| ILMNIllumina Inc | -2.52 | -0.85% |
| MRNAModerna Inc | +1.88 | +2.77% |
Data as of 6:33pm ET, 09/18/2020
Financials
| Next reporting date | November 3, 2020 |
| EPS forecast (this quarter) | $3.80 |
| Annual revenue (last year) | $23.3B |
| Annual profit (last year) | $7.8B |
| Net profit margin | 33.71% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Thousand Oaks, California |
Forecasts
